Space Peptides, a Space Pharmaceuticals company, announces that it is entering into a new facility at the Xiamen National Science Park to enhance its process development capabilities and peptide production.
The site has a size of 3000 square meters, providing cleanroom capabilities, process development laboratory and a production capacity of 15 kg/year.
“Our new pilot plant provides greater flexibility to respond to customer needs in research and development”, said Dr. Runze He, CEO of Space Pharmaceuticals, “capable of handling multiple projects simultaneously, it also enables small scale production of test batches for formulation or testing and validation”.